Estrogen News and Research

Latest Estrogen News and Research

Elagolix drug suppresses ovarian hormone production, prevents heavy menstrual bleeding

About 50 % of women with uterine fibroids--non-cancerous muscle tumors that grow in the uterus--experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended when these symptoms are severe enough to prompt a woman to seek treatment.

23 Jan 2020

New study to measure effects of environmental exposure on young women's breasts

A University of Massachusetts Amherst cancer epidemiologist has received a $462,000 grant from the National Institutes of Health to expand her research into the effects of endocrine-disrupting chemicals on the breast density of college-age women. High breast density is a strong risk factor for breast cancer.

23 Jan 2020

Having children and breastfeeding lowers risk of premature menopause

A new study published in the journal JAMA Network Open reports that early menopause is less likely to happen in women who have had one or more pregnancies that went beyond 6 months, and in women who nursed their babies. Exclusive breastfeeding was associated with the lowest risk.

22 Jan 2020

Early menopause tied to multiple health problems later in life

Menopause marks the end of a woman’s reproductive years, which normally occurs in their 50s. The time at which a woman undergoes menopause may indicate future health status, with those having premature menopause at a higher risk of developing multiple and chronic health problems, a new study found.

20 Jan 2020

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

It is known that the tumor microenvironment plays an important role in the progression of cancer. But could estrogen present in this microenvironment facilitate the growth of liver metastases in women affected by colon, pancreatic and lung cancers?

17 Jan 2020

3D structure of DNA is 'rewired' in hormone-resistant ER+ breast cancers

Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.

16 Jan 2020

BPA activates immune response in mice that persists for at least three generations

Some plastic food and beverage containers still contain bisphenol A, which can mimic the hormone estrogen. Although experts say that small amounts of BPA detected in foods are unlikely to cause problems, some people worry that constant low-level exposures could have health effects, especially for developing fetuses, infants and children.

16 Jan 2020

Women who have more sex less likely to have early menopause

Women who have sex more are at a reduced risk of experiencing early menopause, a new study found. The new finding raises the possibility of lifestyle practices as a predictor of when menopause will occur.

15 Jan 2020

Updated breast cancer guideline offers recommendations for handling cases with low ER expression

The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.

13 Jan 2020

Researchers study the effects of antidepressants to identify the least harmful drugs

About one in ten women in Québec will suffer from depression during pregnancy. Without treatment, the illness carries risks for both mother and child.

8 Jan 2020

Major genetic study provides most comprehensive map of breast cancer risk variants to date

A major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's risk of developing the disease. The scientists involved say these errors may influence as many as 190 genes.

7 Jan 2020

New drug compounds thwart master regulator of tumor growth, metastasis

Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes.

7 Jan 2020

Discovery could pave way for new breast cancer drugs

Eric Prossnitz, PhD, hopes to help many of the 12% of American women who are projected to be diagnosed with breast cancer in their lifetimes.

7 Jan 2020

Review reveals difference in heart disease between men and women

More women than men die of heart failure. The reason is that only 50 per cent of the heart failure cases among women are caused by having a heart attack, which can be treated with modern methods.

6 Jan 2020

Scientists develop computationally inspired method for preclinical study of anxiety

Nearly 40 million people in the U.S. have an anxiety disorder. While treatment options exist, treatment success varies, and many people do not respond to treatment until weeks or months after they begin anti-depressants

18 Dec 2019

What and why every woman needs to know about dense breasts

Two new state laws targeting breast cancer screenings and dense breasts have been passed in Illinois since 2018.

17 Dec 2019

The evidence for BRCA1/2 or any genetic testing in breast cancer patients

A new statement by the American College of Medical Genetics and Genomics (ACMG), published in the journal Genetics in Medicine, discusses the place of germline genetic testing in breast cancer patients.

15 Dec 2019

Patient-reported outcomes linked to aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to research findings to be presented Friday, Dec. 13 at the San Antonio Breast Cancer Symposium.

13 Dec 2019

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

Should germline genetic testing be offered to all patients with breast cancer? The American College of Medical Genetics and Genomics addresses this important question in a new statement published in Genetics in Medicine, "Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics."

13 Dec 2019

ACMG recommends evaluations of breast cancer patients before genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organization's official journal, Genetics in Medicine, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

13 Dec 2019

Estrogen News and Research

Latest Estrogen News and Research

Elagolix drug suppresses ovarian hormone production, prevents heavy menstrual bleeding

New study to measure effects of environmental exposure on young women's breasts

Having children and breastfeeding lowers risk of premature menopause

Early menopause tied to multiple health problems later in life

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

3D structure of DNA is 'rewired' in hormone-resistant ER+ breast cancers

BPA activates immune response in mice that persists for at least three generations

Women who have more sex less likely to have early menopause

Updated breast cancer guideline offers recommendations for handling cases with low ER expression

Researchers study the effects of antidepressants to identify the least harmful drugs

Major genetic study provides most comprehensive map of breast cancer risk variants to date

New drug compounds thwart master regulator of tumor growth, metastasis

Discovery could pave way for new breast cancer drugs

Review reveals difference in heart disease between men and women

Scientists develop computationally inspired method for preclinical study of anxiety

What and why every woman needs to know about dense breasts

The evidence for BRCA1/2 or any genetic testing in breast cancer patients

Patient-reported outcomes linked to aromatase inhibitor adherence

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

ACMG recommends evaluations of breast cancer patients before genetic testing

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Estrogen News and Research

Latest Estrogen News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in